121 related articles for article (PubMed ID: 2735319)
21. Reciprocal translocation (11;19)(q23;p13) in congenital acute lymphoblastic leukemia.
Heim S; Kristoffersson U; Mandahl N; Mitelman F; Bekassy AN; Garwicz S; Heldrup J; Wiebe T
Cancer Genet Cytogenet; 1986 Nov; 23(3):239-44. PubMed ID: 3464343
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal abnormalities in childhood acute nonlymphocytic leukemia (M4).
Mostafavipour SH; Abulaban M; Alali K; al Zaman A; Macera MJ; Verma RS
Cancer Genet Cytogenet; 1991 Dec; 57(2):195-200. PubMed ID: 1756498
[TBL] [Abstract][Full Text] [Related]
23. Translocation t(1;11)(q21;q23): a new finding in congenital acute myeloid leukemia.
Reynaert N; Vandenberghe P; Boeckx N; Renard M; Uyttebroeck A; Labarque V
Leuk Lymphoma; 2014 Jun; 55(6):1435-6. PubMed ID: 24001130
[No Abstract] [Full Text] [Related]
24. t(2;14)(q23;q32.3) as the sole abnormality in a patient with acute nonlymphocytic leukemia (FAB-M4).
Columbano-Green LM; Romain DR; Carter J; Crossen PE
Cancer Genet Cytogenet; 1990 Sep; 48(2):255-7. PubMed ID: 2397456
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
26. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
27. [Acute myeloblastic leukemia without maturation (AML-M1) with basophilic elements and associated with translocation t(6;9)].
Dimicoli S; Fohlen-Walter A; Mansuy L; Buisine J; Grégoire MJ; Lecompte T; Bordigoni P; Jonveaux P; Lesesve JF
Ann Biol Clin (Paris); 2003; 61(3):352-7. PubMed ID: 12805015
[TBL] [Abstract][Full Text] [Related]
28. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
Nichols CR; Breeden ES; Loehrer PJ; Williams SD; Einhorn LH
J Natl Cancer Inst; 1993 Jan; 85(1):36-40. PubMed ID: 7677934
[TBL] [Abstract][Full Text] [Related]
29. Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.
Wang L; Wu XY; Jin RM; Zhang BY; Qiu YN
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):807-810. PubMed ID: 29058300
[TBL] [Abstract][Full Text] [Related]
30. Etoposide in the treatment of leukemias.
Bishop JF
Semin Oncol; 1992 Dec; 19(6 Suppl 13):33-8. PubMed ID: 1492226
[TBL] [Abstract][Full Text] [Related]
31. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia.
Kantarjian HM; Keating MJ; McCredie KB; Beran M; Walters R; Dalton WT; Hittleman W; Freireich EJ
J Clin Oncol; 1985 Jun; 3(6):793-8. PubMed ID: 3859586
[TBL] [Abstract][Full Text] [Related]
32. 8;21 translocation in acute nonlymphocytic leukemia. Occurrence in M1 and M2 FAB subtypes.
Davey DD; Patil SR; Echternacht H; Fatemi C; Dick FR
Am J Clin Pathol; 1989 Aug; 92(2):172-6. PubMed ID: 2756934
[TBL] [Abstract][Full Text] [Related]
33. Etoposide in leukemia.
Bishop JF; Lowethal R; Joshua D; Matthews JP; Wolf MM; Cooper IA
Cancer; 1991 Jan; 67(1 Suppl):285-91. PubMed ID: 1984829
[TBL] [Abstract][Full Text] [Related]
34. Recurrent involvement of 11q13 in acute nonlymphocytic leukemia.
Sait SN; Dal Cin P; Sandberg AA
Cancer Genet Cytogenet; 1987 Jun; 26(2):351-4. PubMed ID: 3471314
[TBL] [Abstract][Full Text] [Related]
35. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
Gozzetti A; Calabrese S; Raspadori D; Crupi R; Tassi M; Bocchia M; Fabbri A; Lauria F
Cancer Genet Cytogenet; 2007 Aug; 177(1):81-2. PubMed ID: 17693199
[No Abstract] [Full Text] [Related]
36. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D
J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913
[TBL] [Abstract][Full Text] [Related]
37. 11;13 translocation in acute nonlymphocytic leukemia.
Sugita K; Kurosawa H; Sakakibara H; Eguchi M; Furukawa T; Hanada R
Acta Haematol; 1992; 87(4):198-201. PubMed ID: 1519435
[TBL] [Abstract][Full Text] [Related]
38. Translocation t(11;19)(q23;q13.1) without MLL Rearrangement in Acute Myeloid Leukemia: Heterogeneity of the 11q23 Breakpoints.
Yamamoto K; Kawamoto S; Kakiuchi S; Yakushijin K; Matsuoka H; Minami H
Acta Haematol; 2015; 134(2):76-9. PubMed ID: 25895667
[No Abstract] [Full Text] [Related]
39. A novel karyotype in acute myeloid leukemia with basophilia.
Servitzoglou M; Grenzelia M; Baka M; Harisi M; Pourtsidis A; Bouhoutsou D; Varvoutsi M; Doganis D; Dana H; Divane A; Kosmidis H
Pediatr Hematol Oncol; 2014 Mar; 31(2):149-56. PubMed ID: 24552500
[TBL] [Abstract][Full Text] [Related]
40. CKIT mutation in therapy-related acute myeloid leukemia with MLLT3/MLL chimeric transcript from t(9;11)(p22;q23).
Jung CL; Kim HJ; Kim DH; Huh H; Song MJ; Kim SH
Ann Clin Lab Sci; 2011; 41(2):193-6. PubMed ID: 21844580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
